A carregar...
Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
Melanocortin-1 receptor (MC1R) and very late antigen-4 (VLA-4, integrin α(4)β(1)) are 2 attractive molecular targets for developing peptide radiopharmaceuticals for melanoma imaging and therapy. MC1R- and VLA-4–targeting peptides and peptide-conjugated Cornell prime dots (C′ dots) can serve as deliv...
Na minha lista:
| Publicado no: | J Nucl Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Society of Nuclear Medicine
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049342/ https://ncbi.nlm.nih.gov/pubmed/33277401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.243840 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|